Roth Capital analyst Jeff Martin maintained a Buy rating on NV5 Global but lowered his price target to $90 from $97 following the company's in line Q4 results. In a research note to investors, Martin says his investment thesis on NV5 centers around continued execution on strong organic growth, coupled with accretive acquisitions that expand geographic reach and service capability. He believes management's disciplined approach to M&A commands a premium valuation to peers and feels that fundamentals of the business are sound and that the material weakness is not a market-driving event.